Ovid Therapeutics Stock (NASDAQ:OVID), Quotes and News Summary

Q: What sector and industry does Ovid Therapeutics (OVID) operate in?

Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Ovid Therapeutics Stock (NASDAQ: OVID) stock price, news, charts, stock research, profile.

Open	$3.090
Close	$3.070
Volume / Avg.	67.140K / 209.470K
Day Range	3.030 - 3.120
52 Wk Range	2.570 - 4.139
Market Cap	$223.054M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	4.8%
Days to Cover	5.48

Recent News

Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications

New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this week.

Vandana Singh

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead

In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating risks to millions of people," including those in states where abortion remains legal.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ovid Therapeutics (OVID) stock?

You can purchase shares of Ovid Therapeutics (NASDAQ: OVID) through any online brokerage.

View our list of the best stock brokerages.

Who are Ovid Therapeutics's (OVID) competitors?

Other companies in Ovid Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Renovaro (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).

What is the target price for Ovid Therapeutics (OVID) stock?

The latest price target for Ovid Therapeutics (NASDAQ: OVID) was reported by B. Riley Securities on Tuesday, April 30, 2024. The analyst firm set a price target for 9.00 expecting OVID to rise to within 12 months (a possible 185.71% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Ovid Therapeutics (OVID)?

The stock price for Ovid Therapeutics (NASDAQ: OVID) is $3.15 last updated Today at May 2, 2024 at 4:25 PM EDT.

Does Ovid Therapeutics (OVID) pay a dividend?

There are no upcoming dividends for Ovid Therapeutics.

When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?

Ovid Therapeutics’s Q2 earnings are confirmed for Friday, August 2, 2024.

Is Ovid Therapeutics (OVID) going to split?

There is no upcoming split for Ovid Therapeutics.

What sector and industry does Ovid Therapeutics (OVID) operate in?

Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-